132364-79-5

Basic information

• Product Name: 5-(4-methylphenyl)-3-[(2-pyridylamino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione
• CAS NO: 132364-79-5
• Molecular Weight: 298.368
• Mol File: 132364-79-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-(4-methylphenyl)-3-[(2-pyridylamino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-methylphenyl)-3-[(2-pyridylamino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione(132364-79-5)
• EPA Substance Registry System: 5-(4-methylphenyl)-3-[(2-pyridylamino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione(132364-79-5)

Safety Data

• Hazardous Substances Data: 132364-79-5(Hazardous Substances Data)

Upstream product

• 504-29-0 2-aminopyridine 
• 31130-15-1 5-(4-methylphenyl)-1,3,4-oxadiazoline-2(3H)-thione 
• 50-00-0 formaldehyd 

Relevant articles and documents

Synthesis of some novel 3,5-disubstituted 1,3,4-oxadiazole derivatives and anticancer activity on EAC animal model

A series of novel 3,5-disubstituted 1,3,4-oxadiazole- 2-thione derivatives (1e, 2e, 3e, 4e, and 5e) have been synthesized from different substituted aromatic acids. The structure determination of these compounds have been made on the basis of IR, 1H NMR, and Elemental analysis. The effect of all the compounds on tumor growth inhibition was evaluated by studying the parameters-tumor volume, percentage of the tumor cell count (viable and nonviable), hematological values, and the mean survival status of the treated animals on eight groups of Swiss albino mice. Compounds were given at the dose of 50 mg/kg body weight intraperitoneally and all exhibited the significant (P0.001) anticancer activity compared to control. 5-Fluorouracil was used as a standard drug (20 mg/kg body weight i.p.) in the study. All the compounds demonstrated a prominent anticancer activity. The study supported the derivatives of oxadiazoles for the development as potent anticancer molecules. Springer Science+Business Media, LLC 2010.